HANISH ARNOLD C — SEC insider filings

SEC reporting owner CIK 1233253. 23 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-08-24 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
OMEROS CORP (OMER)Director10—4 legs · 20,000 sh · $314,39417
Decoy Therapeutics Inc. (DCOY)Director137 legs · 55,350 sh · $38,6722 legs · 27 sh · $175

Insider filings — HANISH ARNOLD C

FiledFormIssuerReported transactionsSource
2026-09-024Decoy Therapeutics Inc. (DCOY)Grant/award (A): 3,000 @ $0EDGAR
2026-08-284OMEROS CORP (OMER)Option exercise (M): 5,000 @ $15.81 · Sale (S): 5,000 @ $18.53 · Option exercise (M): 2,500 @ $15.81 · Option exercise (M): 7,500 @ $14.66 · Sale (S): 5,000 @ $18.88 · Sale (S): 5,000 @ $19.02 · +3 moreEDGAR
2026-06-224OMEROS CORP (OMER)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-01-024Salarius Pharmaceuticals, Inc. (SLRX)Sale (S): 15 @ $0.64 · Sale (S): 12 @ $0.64EDGAR
2025-11-244Salarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 5,000 @ $0.75EDGAR
2025-07-014OMEROS CORP (OMER)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-074OMEROS CORP (OMER)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-02-224Salarius Pharmaceuticals, Inc. (SLRX)Grant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-274OMEROS CORP (OMER)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-05-234OMEROS CORP (OMER)Option exercise (M): 5,000 @ $5.30 · Sale (S): 5,000 @ $6.46 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-01-054Salarius Pharmaceuticals, Inc. (SLRX)Grant/award (A): 1,440 @ $0EDGAR
2022-09-234OMEROS CORP (OMER)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-224OMEROS CORP (OMER)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-064/ASalarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 3,000 @ $3.59EDGAR
2022-06-064/ASalarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 4,350 @ $1.15EDGAR
2022-06-064/ASalarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 4,000 @ $0.98EDGAR
2022-06-064Salarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 28,000 @ $0.18EDGAR
2022-02-144OMEROS CORP (OMER)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-01-214Salarius Pharmaceuticals, Inc. (SLRX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-09-094OMEROS CORP (OMER)Option exercise (M): 10,000 @ $9.44 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-08-114Salarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 7,000 @ $0.88EDGAR
2020-12-044Salarius Pharmaceuticals, Inc. (SLRX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2020-08-244Salarius Pharmaceuticals, Inc. (SLRX)Purchase (P): 4,000 @ $0.98EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1233253 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs